Cyclophosphamide, an alkylating agent, has rarely been observed to cause a bluish discoloration of nails, an occurrence that is typically underreported. We describe the case of a middle-aged male undergoing dexamethasone-cyclophosphamide pulse therapy for pemphigus foliaceus, who exhibited bluish-gray discoloration of the nails. It is crucial to differentiate this presentation from other conditions such as nail apparatus melanoma (NAM), which may manifest in a slightly different manner. We also report the onychoscopic findings observed in this case.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11056765PMC
http://dx.doi.org/10.7759/cureus.57233DOI Listing

Publication Analysis

Top Keywords

bluish-gray discoloration
8
pemphigus foliaceus
8
discoloration nails
8
onychoscopic analysis
4
analysis cyclophosphamide-induced
4
cyclophosphamide-induced polydactylic
4
polydactylic bluish-gray
4
discoloration case
4
case pemphigus
4
foliaceus cyclophosphamide
4

Similar Publications

Cyclophosphamide, an alkylating agent, has rarely been observed to cause a bluish discoloration of nails, an occurrence that is typically underreported. We describe the case of a middle-aged male undergoing dexamethasone-cyclophosphamide pulse therapy for pemphigus foliaceus, who exhibited bluish-gray discoloration of the nails. It is crucial to differentiate this presentation from other conditions such as nail apparatus melanoma (NAM), which may manifest in a slightly different manner.

View Article and Find Full Text PDF

Introduction: Immune checkpoint inhibitors have improved clinical outcomes in a wide range of cancers. While skin toxicity is not uncommon with immune checkpoint inhibitors, generalized nail discoloration has not been reported with their use in oncology.

Case Report: Herein, we report a unique case of bluish-gray fingernail discoloration due to nivolumab therapy for relapsed melanoma.

View Article and Find Full Text PDF

[Bluish-gray discoloration of skin and conjunctiva].

Ophthalmologe

January 2020

Arbeits- und Verkehrsmedizin, Delmenhorster Str. 1, 50735, Köln, Deutschland.

Colloidal silver used as a suspension for (alternative) therapeutic purposes or silver exposure due to environmental or working conditions can lead to irreversible deposits of silver granules in the skin (bluish-gray hue of the skin), mucosa, cornea, retina and internal organs. Silver-induced discoloration of the conjunctiva should therefore be taken into account when a bluish-gray discoloration raises the suspicion of conjunctival melanoma.

View Article and Find Full Text PDF

Imipramine-induced hyperpigmentation.

Cutis

September 2017

Department of Dermatology, Baylor Scott & White Health, Texas A&M Health Science Center, Temple, USA.

Imipramine is a tricyclic medication that has been used for the treatment of depression and other mood disorders. Although rare, a slate gray discoloration of sun-exposed skin may occur in patients taking this medication. We present the case of a 63-year-old woman who had been taking imipramine for depression for more than 20 years when she developed a bluish gray discoloration on the face and neck that was diagnosed as imipramine-induced hyperpigmentation based on histopathology and clinical history.

View Article and Find Full Text PDF

The differential diagnosis of bluish-gray pigmentation of the skin includes dermal melanocytosis, malignant melanoma and metallic discoloration. Of these disorders, metallic discoloration, which develops from deposits of fine metallic particles on the skin, is an uncommon dermatologic disease. We report a case of metallic discoloration of the right shin caused by titanium alloy prostheses in a patient with right total knee replacement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!